Input Sample Clauses

Input. Client shall be solely responsible for the input, transmission, or delivery to and from Fiserv of all information and data required by Fiserv to perform Services unless Client has retained Fiserv to handle such responsibilities, as specifically set forth in the Exhibits. The information and data shall be provided in a format and manner approved by Fiserv. Client will provide at its own expense or procure from Fiserv all equipment, computer software, communication lines, and interface devices required to access the Fiserv System. If Client has elected to provide such items itself, Fiserv shall provide Client with a list of compatible equipment and software; Client agrees to pay Fiserv's standard fee for recertification of the Fiserv System resulting therefrom.
Input. Each Party will regularly provide the other with copies of all applications for Patents within its respective Licensed IP, and all other material submissions and correspondence with any patent authorities regarding such Patents, in sufficient time to allow for review and comment by the other Party. In addition, each Party will provide the other Party and its counsel with an opportunity to consult with such Party and its counsel regarding Prosecution and Maintenance of any such Patents within the Field, and such Party will consider in good faith all such comments timely made by such other Party and its counsel. In the event of any disagreement between the Parties, the licensor Party will have the final decision-making authority with respect to the matter involved as long as the licensor Party acts in good faith.
Input. Theravance shall regularly advise Clinigen of the status of all Theravance Patents in the Territory, and, at Clinigen’s request, shall provide Clinigen with copies of all documentation concerning Theravance Patents in the Territory, including all correspondence to and from any Governmental Authority. Prior to filing patent applications relating to Theravance Inventions or significant prosecution documents relating to Theravance Patents in the Territory, Theravance shall solicit Clinigen’s advice on the content of the patent application or prosecution document and Theravance shall take into account Clinigen’s reasonable comments related thereto, unless (without fault of Theravance) deadlines will not permit such review or Clinigen notifies Theravance that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, Theravance shall have the final decision-making authority with respect to any action relating to Theravance Inventions or Theravance Patents subject to the provisions of Section 13.02(d) and Section 13.02(i). Theravance and Clinigen shall agree on which Countries in the Territory corresponding Theravance Patents shall be filed within the priority period. For all Countries outside the Territory, Theravance shall make the final decision regarding which Countries corresponding Theravance Patents shall be filed.
Input. Document 1 ID PowerDocs://RPC_DOCS1/11272132/1 Description RPC_DOCS1-#11272132-v1-LMA_NON_RT_2005 Document 2 ID PowerDocs://RPC_DOCS1/11585152/15 Description RPC_DOCS1-#11585152-v15-LMA_NRT_TOBA_-_2011_VERSION Rendering set RPC Standard Legend: Insertion Deletion Moved from Moved to Style change Format change Moved deletion Inserted cell Deleted cell Moved cell Split/Merged cell Padding cell Statistics: Count Insertions 83 Deletions 65 Moved from 0 Moved to 0 Style change 0 Format changed 0
Input. MYLAN shall regularly advise THERAVANCE of the status of all MYLAN Product Patents and, at THERAVANCE’s request, shall provide THERAVANCE with copies of all documentation concerning MYLAN Product Patents, including all correspondence to and from any Governmental Authority. Prior to filing patent applications or significant prosecution documents relating to MYLAN Product Patents, MYLAN shall solicit THERAVANCE’s advice on the content of the patent application or prosecution document and MYLAN shall take into account THERAVANCE’s reasonable comments related thereto, unless (without fault of MYLAN) deadlines will not permit such review or THERAVANCE notifies MYLAN that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, MYLAN shall have the final decision-making authority with respect to any action relating to MYLAN Product Patents subject to the provisions of Section 12.02(e) or Section 12.02(h), although THERAVANCE and MYLAN shall seek to agree on which Countries in the Territory in which MYLAN Product Patents shall be filed within the priority period and the content of patent applications or prosecution documents with respect to the MYLAN Product Patents.
Input. AECL shall be responsible for acquiring all inputs, fuel, heavy water, chemicals, targets, inventory and other raw materials (collectively, the "Raw Materials") required to supply the Isotopes and perform the Services in accordance with the Production and Supply Standards except for Iridium-192 capsules required to produce Iridium-192, Tellurium Dioxide capsules required to produce Iodine-131, and all waste cans for Category I waste, which will be supplied by Nordion to AECL without charge.
Input. 211 Each academic department, including the University Library, has a Departmental Input Document providing for input of Faculty. To the extent that those department Faculty procedures permit (or are subsequently amended to permit), Employee participation on curriculum and instruction committees will be allowed. 212 To the extent that Employee access to full Faculty meetings is provided by currently agreed upon (or subsequently amended), Faculty input procedures, Employees shall be permitted to attend such meetings and provide recommendations on curricular matters. 213 Further, if the department Faculty procedures do not permit Employee participation, Employees will be given an opportunity to confer periodically with the Department Head on curriculum and instruction issues. 214 B. Communications 215 Employees shall have full access to all communications and documents including announcements, agendas, minutes, and other department items of business pertinent to their assignments. 216 Employees shall be given the opportunity to confer periodically with their Department Head on qualifications, curriculum, instruction, and workload issues. 217 In the first month of fall and winter semesters, each department/school will hold a meeting for Employees to explain ongoing EMU, College or Division, Department/School and Program practices (policies, rules, and regulations), to discuss curriculum, instruction, and workload issues, and to solicit advice and recommendations from Employees regarding departmental matters. The Union and Employees shall be notified in writing at least two weeks in advance of the meeting. Each academic unit will make fifteen (15) minutes available to the Union during the meeting. 218 Prior to scheduling courses for each semester, each Employee will have the opportunity to provide information in writing regarding preferred teaching assignments, willingness to teach overload courses, and preferred days, times, and locations of classes. For Employees who are assigned off-campus student teaching or clinical supervision, Employees may request placement in a particular geographic area. Final decisions regarding any of the above items rest solely with the Employer.
Input a, b, u q such that b = as + e and u = asj + ej for some ∼ s, sj, e, ej Ψn ∈ { } ⊕ ≤ ⊕ ≤ Task: find S 0, 1 A such that HW(S ıvı) t and HW(S ıvjı) t, where v = us and vj = bsj. Noisy Key Distinguishing (NKD). ∈ R ∈ { } Input: a, b, u q and S 0, 1 A such that b = as +e and u = asj +ej ∼ for some s, sj, e, ej Ψn ⊕ ≤ ⊕ ≤ Task: output 1 if HW(S ıvı) t and HW(S ıvjı) t, where v = us and vj = bsj; and 0 otherwise. S Ramstake [50]. Ramstake operates on integers modulo a large Mersenne prime p, the set of which we denote by Zp. Smallness is associated with having a bit expansion of low Hamming weight. We denote this set of sparse integers by . The functionalities and noisy key views are as follows. Init: sample A ∈ Zp AContr: sample b, c ←−$ S and transmit D = Ab + c mod p BContr: sample bj, cj ←−$ S and transmit Dj = Abj + cj mod p AConv: compute E = Dja mod p BConv: compute Ej = Daj mod p SA: ıEı SB: ıEjı The problems of recovering either participant’s state is in fact an affine variant of the low-Hamming weight ratio problem introduced by Aggarwal et al. [1]. Paraphrased but without loss of generality, this problem asks to find low-Hamming-weight integers f and g such that the given integer H satisfies f × (−H) + g = 0 mod p. A State Recovery (ASR). Input: A, D ∈ Zp s.t. D = Ab + c for some b, c ∈ S Task: find b, c ∈ S s.t. D = Ab + c Noisy Key Search (NKS). B State Recovery (BSR). Input: A, Dj ∈ Zp s.t. Dj = Abj + cj for some bj, cj ∈ S Task: find bj, cj ∈ S s.t. Dj = Abj +cj ∈
Input. Theravance shall regularly advise Clinigen of the status of all Joint Invention Patents and, at Clinigen’s request, shall provide Clinigen with copies of all ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. documentation concerning Joint Invention Patents, including all correspondence to and from any Governmental Authority. Prior to filing patent applications relating to Joint Inventions or significant prosecution documents relating to Joint Invention Patents, Theravance shall solicit Clinigen’s advice on the content of the patent application or prosecution document and Theravance shall take into account Clinigen’s reasonable comments related thereto, unless (without fault of Theravance) deadlines will not permit such review or Clinigen notifies Theravance that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, Theravance shall have the final decision-making authority with respect to any action relating to Joint Inventions or Joint Invention Patents subject to the provisions of Section 13.02(f) and Section 13.02(i). Theravance and Clinigen shall agree on which Countries in the Territory corresponding Joint Invention Patents shall be filed within the priority period. For all Countries outside the Territory, Theravance shall make the final decision regarding which Countries corresponding Joint Invention Patents shall be filed subject to the provisions of Section 13.02(f).
Input. Client notification via the client portal runs from the Client contact person to the Service Provider help desk. The call must contain the following components:  Name of the person reporting the call;  Telephone number and email address of the person reporting the call;  The date (possibly time too) the Incident occurred;  Description of the incident;  Module where the incident occurred;  An estimated priority by the Client.